|
|
5350 Transportation Blvd., Suite 18
Garfield Heights, OH 44125 USA
phone:216.587.5566
fax:216.587.3388
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.axiomed.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| AxioMed Spine Corporation, located in Cleveland, Ohio, was formed in 2001 to develop products with a goal of restoring spinal function to patients with degenerative spine disease; thus advancing the standard of care beyond fusion and first generation arti |
|
| Management |
| Patrick McBrayer, President and Chief Executive Officer; James Kuras, Chief Operating Officer; Mr. Baty, Chief Financial Officer; Neal Defibaugh, Vice President for Clinical and Regulatory affairs; Peter Kleinhenz, Chairman |
| |
|
|
| |
|
| Keywords |
| polymer, biomechanics, pathology, spine surgery, science |
|
|
|
| Description |
|
AxioMed Spine Corporation, located in Cleveland, Ohio, was formed in 2001 to develop products with a goal of restoring spinal function to patients with degenerative spine disease; thus advancing the standard of care beyond fusion and first generation artificial discs. Since its inception, AxioMed has secured over $34M in private equity financing from prestigious venture capitalists. The company�s Freedom� Lumbar Disc has been developed and clinical trials initiated. The company is headed by CEO, Patrick McBrayer, who joined AxioMed in early 2006. Mr. McBrayer along with founder and COO, James Kuras, lead an experienced management and development team with significant history and expertise in spinal implants, including early artificial disc development efforts. Company employment includes professionals with extensive spine and engineering experience. The team is augmented by a Medical Advisory Panel of surgeons from leading spine centers and universities. The company�s headquarters include product development and testing, clinical and regulatory affairs, and manufacturing. AxioMed will leverage its background in lumbar disc replacement with an ongoing development project for the cervical spine |
|
| Products / Services |
AxioMed's Freedom Lumbar Disc is an artificial spinal disc intended for use in the lumbar spine. The company will leverage its background in lumbar disc replacement with an ongoing development project for the cervical spine.
|
|
| Technology / Differentiation |
| Based upon its viscoelastic prosthetic technology, AxioMed has designed and patented an artificial disc for use in the lumbar spine: the Freedom Lumbar Disc. Using a patented polymer under exclusive license, AxioMed has been able to develop the next generation of artificial disc. The material characteristics of the polymer, in combination with the implant design, provide three-dimensional motion that biomechanical testing has shown functions within the natural biomechanics of the spine. |
|
| Market / Customers |
The market for artificial discs is developing rapidly, possibly exceeding $1 billion in 2008 and reaching $3 billion by the end of the decade. Currently, spinal disc replacement serves as the most promising alternative to spinal fusion, which is currently used to treat spinal disease.
|
|
| Status |
| AxioMed anticipated receiving a CE mark for the Freedom Lumbar Disc in late 2008 and proceeding with commercialization in Europe thereafter. In addition, the U.S. FDA has approved an IDE pivotal study for the Freedom Lumbar Disc; the company will initiate this study in late 2008. Since its inception in 2001, AxioMed has secured over $24 million in private equity financing from prestigious venture capitalists. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members